Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117603445 | 11760344 | 5 | F | 20151110 | 20160727 | 20151120 | 20160803 | EXP | PHHY2015BR151581 | NOVARTIS | 63.31 | YR | F | Y | 49.00000 | KG | 20160804 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117603445 | 11760344 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, EVERY 30 DAYS | SC731 | 21008 | 20 | MG | VIAL | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117603445 | 11760344 | 1 | Acromegaly |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117603445 | 11760344 | HO |
| 117603445 | 11760344 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117603445 | 11760344 | Abdominal distension | |
| 117603445 | 11760344 | Abdominal pain | |
| 117603445 | 11760344 | Anxiety | |
| 117603445 | 11760344 | Apnoea | |
| 117603445 | 11760344 | Arrhythmia | |
| 117603445 | 11760344 | Blood cholesterol increased | |
| 117603445 | 11760344 | Blood growth hormone increased | |
| 117603445 | 11760344 | Carotid artery occlusion | |
| 117603445 | 11760344 | Concomitant disease aggravated | |
| 117603445 | 11760344 | Diabetes mellitus | |
| 117603445 | 11760344 | Dizziness | |
| 117603445 | 11760344 | Fatigue | |
| 117603445 | 11760344 | Glaucoma | |
| 117603445 | 11760344 | Headache | |
| 117603445 | 11760344 | Hypercoagulation | |
| 117603445 | 11760344 | Infection | |
| 117603445 | 11760344 | Insulin-like growth factor increased | |
| 117603445 | 11760344 | Loss of consciousness | |
| 117603445 | 11760344 | Malaise | |
| 117603445 | 11760344 | Memory impairment | |
| 117603445 | 11760344 | Musculoskeletal stiffness | |
| 117603445 | 11760344 | Myocardial infarction | |
| 117603445 | 11760344 | Pain in extremity | |
| 117603445 | 11760344 | Peripheral swelling | |
| 117603445 | 11760344 | Procedural pain | |
| 117603445 | 11760344 | Respiratory arrest | |
| 117603445 | 11760344 | Rheumatic disorder | |
| 117603445 | 11760344 | Vein disorder | |
| 117603445 | 11760344 | Visual impairment | |
| 117603445 | 11760344 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117603445 | 11760344 | 1 | 2009 | 0 |